Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In 2015, the UK became the first country in the world to have a comprehensive routine meningococcal vaccine programme targeting all of the main capsular groups of N. meningitidis. 1 An infant vaccine programme against meningococcal capsular group B Neisseria meningitidis (MenB) was launched from 1st September with an aim to reduce endemic MenB disease in early childhood. On 1st August 2015, an adolescent programme against groups A, C, W and Y meningococci (MenACWY) was rolled out to halt a growing outbreak of capsular group W disease (MenW) caused by a hypervirulent clone of N. meningitidis, in addition to maintaining control against MenC disease provided by the current adolescent programme. 2.

Original publication

DOI

10.1136/archdischild-2015-308928

Type

Journal article

Journal

Arch Dis Child

Publication Date

01/2016

Volume

101

Pages

91 - 95

Keywords

Immunisation, Infectious Diseases, Adolescent, Age Distribution, Child, Child, Preschool, England, Humans, Immunization Programs, Infant, Infant, Newborn, Meningococcal Infections, Meningococcal Vaccines, United Kingdom, Vaccines, Conjugate, Young Adult